Form 4: SeaStar Medical Director Awarded 8,000 Restricted Stock Units
SEC Form 4
Director Bernadette N. Vincent of SeaStar Medical Holding Corp. received 8,000 restricted stock units (RSUs) on November 13, 2024, which will vest over three years.
Summary
- Bernadette N. Vincent, a director at SeaStar Medical Holding Corp., was granted 8,000 restricted stock units (RSUs) on November 13, 2024.
- These RSUs represent a contingent right to receive one share of SeaStar Medical's common stock per unit.
- The RSUs will vest in equal installments over three years, specifically on the first, second, and third anniversaries of June 4, 2024.
Sentiment
Score: 7
Explanation: The document reflects a standard practice of equity compensation, which is generally viewed positively as it aligns director interests with shareholders. There are no negative implications.
Positives
- The granting of RSUs to a director aligns their interests with the long-term performance of the company.
- The vesting schedule encourages long-term commitment from the director.
Future Outlook
The RSUs will vest over the next three years, aligning the director's interests with the company's long-term performance.
Industry Context
The granting of stock-based compensation is a common practice in the biotech industry to attract and retain key personnel and align their interests with shareholders.
Comparison to Industry Standards
- Stock-based compensation, such as RSUs, is a standard practice for compensating directors and executives in publicly traded companies, particularly in the biotech sector.
- Companies like Amgen, Gilead Sciences, and Regeneron Pharmaceuticals also use similar equity-based compensation plans to incentivize their leadership.
- The vesting schedule of three years is also a common practice to ensure long-term commitment.
Stakeholder Impact
- The granting of RSUs to a director can be seen positively by shareholders as it aligns the director's interests with the company's long-term success.
- The vesting schedule encourages long-term commitment from the director.
Key Dates
| Date | Description |
|---|---|
| 06/04/2024 | Date from which the vesting schedule of the RSUs is calculated. |
| 11/13/2024 | Date of the transaction where 8,000 RSUs were granted to the director. |
| 12/03/2024 | Date the form was signed by the attorney-in-fact. |
Keywords
Restricted Stock Units, RSU, Director, Stock Grant, SeaStar Medical, ICU, Equity Compensation, Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.